Key result
A 30-year-old male diagnosed with arrhythmogenic right ventricular dysplasia was successfully treated with amiodarone, aspirin, and ramipril, remaining asymptomatic thereafter.
Case Report (n=1)
No
Reports a rare case of Arrhythmogenic Right Ventricular Dysplasia from a tribal zone in Central India.
Alerts clinicians to ARVD in tribal Central India; leaves open regional prevalence and screening needs.
Arrhythmogenic Right Ventricular Dysplasia (ARVD) is under diagnosed cardiomyopathy which commonly presents in young adults with ventricular tachycardia or sudden death. It is characterized pathologically by progressive fibrofatty replacement of the myocardium, primarily of the right ventricular free wall. Clinically, it presents with life-threatening malignant ventricular arrhythmias which may lead to sudden death, most often in young people and athletes. ARVD/C is difficult to diagnose, although standardized diagnostic criteria have been proposed, based on the presence of major and minor criteria encompassing electrocardiographic, arrhythmic, morphofunctional, histopathologic, and genetic factors.
No takes yet. Share an insight, caveat, or question.
Khunte et al. (2015) conducted a case report in Arrhythmogenic right ventricular dysplasia (n=1). Medical management (amiodarone, aspirin, ramipril) was evaluated on Clinical symptoms. A 30-year-old male diagnosed with arrhythmogenic right ventricular dysplasia was successfully treated with amiodarone, aspirin, and ramipril, remaining asymptomatic thereafter.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: